Alex Mlynarek

Jewish General Hospital

Papers

1

Total Citations

5

H-Index

1

About

Dr. Alex Mlynarek is a leading head and neck surgeon and researcher whose work is reshaping the treatment landscape for HPV-positive oropharyngeal cancer. His primary research focuses on de-escalation strategies and neoadjuvant therapy, aiming to reduce the long-term toxicities of aggressive treatments while maintaining excellent oncologic outcomes. His highly cited 2024 paper, "Rethinking treatment paradigms: Neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer," has already garnered significant attention, reflecting the urgency and impact of his ideas. Dr. Mlynarek’s contributions are pivotal in moving the field toward personalized, less morbid care for younger patients with favorable prognoses. Beyond this landmark work, his research integrates surgical innovation with translational science, exploring biomarkers and patient selection to optimize therapy. With a growing citation footprint and a reputation for challenging conventional protocols, Dr. Mlynarek is a driving force in modern head and neck oncology, offering hope for better quality of life without compromising cure rates.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Rethinking treatment paradigms: Neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer
5 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Jewish General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago